Addition of 6 months of androgen deprivation therapy to stereotactic body radiotherapy more than doubled PFS in hormone-sensitive oligorecurrent prostate cancer. Nearly all patients treated with the ...

Bringing Access to Advanced Radiosurgery Close to Home in the North Hills PITTSBURGH - North Hills residents now have access ...

Significantly more facilities prescribe single-fraction stereotactic body radiation therapy than they did 20 years ago, but a minimal number of individuals with non-small cell lung cancer actually ...

A new study conducted by researchers at Queen Elizabeth Hospital Birmingham in Birmingham, Great Britain, evaluated outcomes and toxicity associated with stereotactic radiotherapy in patients with ...

Willy Goldschmidt is among a group of patients from University Hospitals Coventry and Warwickshire NHS Trust who have taken part in the international trial ...

The Phase 2 trial, called ANDROMEDA, is the first study to directly compare two types of PSMA-targeted radiopharmaceuticals when used alongside stereotactic body radiotherapy (SBRT), a focused form of ...

Explore the revolutionary advancements in radiation therapy for cancer treatment, emphasizing precision and patient-centric ...

A former prostate cancer patient who got the all-clear said taking part in a trial that cut his radiotherapy treatments proved "life changing". While most patients have 20 days of radiotherapy over ...

A Rugby hospital charity trustee said a new radiotherapy treatment that could help prostate cancer patients has been ‘life-changing’.

Renal cell carcinoma (RCC) ranks as the eighth most common malignancy in Spain and remains among the top ten globally. Surgical resection—partial or radical nephrectomy—continues to be the curative ...

Within the next month, providers at Fred Hutch – Proton Therapy will be able to offer advanced X-ray radiation, called TrueBeam photon radiation, to those patients who will benefit from this modality.

Impact of Pulmonary Tumor Burden in Favorable Histology Wilms Tumor Outcomes: A Report From the Children's Oncology Group Study AREN0533 To our knowledge, this is the first phase II randomized trial ...